about
Cutaneous manifestations of hepatitis C in the era of new antiviral agentsEffect of rifaximin on gut microbiota composition in advanced liver disease and its complicationsUsefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatmentFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CDiagnosis of bowel diseases: the role of imaging and ultrasonography.Functional and metabolic disorders in celiac disease: new implications for nutritional treatment.Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis.Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up.Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.Identifying the niche controlling melanocyte differentiation.Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulationThe Chp1 chromodomain binds the H3K9me tail and the nucleosome core to assemble heterochromatin.Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.Argonaute and Triman generate dicer-independent priRNAs and mature siRNAs to initiate heterochromatin formation.Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.Accumulation of RNA on chromatin disrupts heterochromatic silencing.Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy.A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis.Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results.The role of small intestinal bacterial overgrowth in Parkinson's diseaseHelicobacter pylori and extragastric diseases--other HelicobactersMinimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study
P50
Q26773669-9A3080C1-ABAE-47DC-99EB-DDFBF8CD81C7Q26775927-30D7123A-A4A4-4ECE-9A7B-62BB77175DF8Q26799914-C4B0F003-4D61-47B9-B6BD-9EAE73373BD4Q30235178-E42D4DE2-DC28-4A6F-A150-B1BB4F507ABFQ30455406-DF750DDD-F22D-4353-966D-29BD87869B68Q34663588-C987A544-2951-443D-A2F1-75456EB028A7Q37662635-09E4FE7A-8839-4C3D-9E3A-E9E04C0337CFQ38148734-5643C47C-7131-4A02-A049-3497DF25629DQ38192256-E5B63568-57CA-40BC-B796-B1536C81C83EQ39165325-CBC28B99-F942-4FEB-B40C-1EE7E176ED56Q39312153-49941104-574E-41B5-9779-A59059B72B95Q39455595-0DCF0202-31D3-4818-BF10-696BB301BA45Q40766056-E1BC69F7-DC8F-4E03-A944-09F318C4E033Q42407730-DC378FD1-C885-487F-8778-AAA9DF2B5914Q46987001-AED1CA3B-7AD9-41BC-A7F9-9D6E043F9999Q47605018-5CC3155E-E94D-464C-BA07-365678BB9EE5Q48145700-C5575E99-87DC-4764-93ED-7B5E9C109659Q49164405-04130D42-FBAD-49F1-B9D6-1EDB4080979EQ49576014-335542B2-2B9E-4FAB-A1C4-DAF0FB4F0D7EQ50748347-0E601080-0B76-44F2-A850-BE3A7CAA4B12Q52693022-25EA6CDE-E485-4B00-B57C-0E52A2BCA2F1Q54312901-7D52614B-6DF5-434D-A344-76CAE214B885Q59153400-8BC43938-38A3-4E58-AE72-13FA67028069Q81249559-137411D0-57D9-46E8-B8DB-CD450FEE090AQ90950687-00B80AF4-C5D1-4E3C-AF42-A4A486B0E9E2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria Assunta Zocco
@ast
Maria Assunta Zocco
@en
Maria Assunta Zocco
@es
Maria Assunta Zocco
@nl
type
label
Maria Assunta Zocco
@ast
Maria Assunta Zocco
@en
Maria Assunta Zocco
@es
Maria Assunta Zocco
@nl
prefLabel
Maria Assunta Zocco
@ast
Maria Assunta Zocco
@en
Maria Assunta Zocco
@es
Maria Assunta Zocco
@nl
P106
P21
P31
P496
0000-0002-0814-9542